Clinical Trial Update: Study to Evaluate Real-world Pharmacoeconomics and Resistance Mechanisms of Panitumumab in Metastatic Colorectal Cancer Patients

View source ↗

Summary

A completed study evaluating real-world pharmacoeconomics and resistance mechanisms of panitumumab in patients with metastatic colorectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Panitumumab (panitumumab)

Snippet

Sponsor: PeriPharm | Conditions: Colorectal Cancer Metastatic | Status: COMPLETED